<SEC-DOCUMENT>0000902664-25-004899-index.html : 20251113 <SEC-HEADER>0000902664-25-004899.hdr.sgml : 20251113 <ACCEPTANCE-DATETIME>20251113091613 ACCESSION NUMBER: 0000902664-25-004899 CONFORMED SUBMISSION TYPE: SCHEDULE 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20251113 DATE AS OF CHANGE: 20251113 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001055726 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 330969592 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-60487 FILM NUMBER: 251475779 BUSINESS ADDRESS: STREET 1: 660 W. GERMANTOWN PIKE STREET 2: SUITE 110 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: 8584103134 MAIL ADDRESS: STREET 1: 660 W. GERMANTOWN PIKE STREET 2: SUITE 110 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 FORMER COMPANY: FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP DATE OF NAME CHANGE: 20050404 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP DATE OF NAME CHANGE: 20011116 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD DATE OF NAME CHANGE: 19980213 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Adage Capital Management, L.P. CENTRAL INDEX KEY: 0001535978 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G BUSINESS ADDRESS: STREET 1: 200 CLARENDON STREET, 52ND FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-867-2800 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET, 52ND FLOOR CITY: BOSTON STATE: MA ZIP: 02116 </SEC-HEADER> <DOCUMENT> <TYPE>SCHEDULE 13G <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>p25-2391exhibit991.htm <DESCRIPTION>JOINT FILING AGREEMENT <TEXT> Document 2 - file: p25-2391exhibit991.htm
</DOCUMENT> </SEC-DOCUMENT>